JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nobili, F.
Right arrow Articles by Darcourt, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nobili, F.
Right arrow Articles by Darcourt, J.

Brain Perfusion Follow-Up in Alzheimer’s Patients During Treatment with Acetylcholinesterase Inhibitors

Flavio Nobili, MD1, Malick Koulibaly, PhD2, Paolo Vitali, MD1, Octave Migneco, MD2, Giuliano Mariani, MD3, Klaus Ebmeier, MD4, Alberto Pupi, MD5, Philippe H. Robert, MD, PhD6, Guido Rodriguez, MD1 and Jacques Darcourt, MD, PhD2

1 Clinical Neurophysiology, Department of Internal Medicine, University of Genoa, Genoa, Italy
2 Nuclear Medicine Department, Laboratory of Biophysics, Centre Antoine Lacassagne, University of Nice, Sophia Antipolis, France
3 Nuclear Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy
4 Department of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom
5 Department of Physiopathology, University of Florence, Florence, Italy
6 Memory Center, Federation of Clinical Neuroscience, CHU-University of Nice, Sophia Antipolis, France



View larger version (44K):

[in a new window]
 
FIGURE 1. (A) z map of decreased rCBF on repeated SPECT examination (t1) compared with baseline examination (t0) in AD nS subgroup. Significant areas (shown as glass brain in upper part and colored areas superimposed on standard 3-dimensional anatomic template [3D render] in lower part) are found at t1 in frontal, temporal, and parietal superficial cortex in right hemisphere and in frontal and mesial temporal cortex in left hemisphere. Left thalamus and right cerebellar lobe are involved to some extent. Maximum difference is found in right precuneus at level of occipital lobe (BA 31) (z = 6.36; corrected P < 0.001 at cluster level; peak Talairach (23) coordinates: 17, -63, 22). (B) z map of decreased rCBF in nS subgroup compared with S subgroup at t1. Significant area is found in left frontal cortex (maximum difference in middle frontal gyrus (BA 11) (z = 3.92; corrected P = 0.02 at cluster level; peak Talairach (23) coordinates: -28, 44, -11). Other details as in A.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.